Ketoprofen 2.5% gel: A clinical overview

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 8, 2011, Pages 943-949

  Coaccioli, Stefano ^a  

^a Santa Maria General Hospital   (Italy)

Author keywords

Gel; Ketoprofen; Musculoskeletal; NSAIDs; Pain; Topical treatment

Indexed keywords

BENZYDAMINE; DICLOFENAC; ETOFENAMATE; FELBINAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; PIROXICAM; PLACEBO; DRUG DERIVATIVE; KETOPROFEN TOPICAL GEL; NONSTEROID ANTIINFLAMMATORY AGENT;

CHRONIC PAIN; CONTUSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; GASTROINTESTINAL DISEASE; GEL; HUMAN; HYPERSENSITIVITY; JOINT STIFFNESS; LOW BACK PAIN; MEDLINE; META ANALYSIS (TOPIC); MUSCULOSKELETAL PAIN; MYOSITIS; NONARTICULAR RHEUMATISM; OSTEOARTHRITIS; PAIN; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRURITUS; REVIEW; SPORT INJURY; SUNLIGHT; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC);

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; HUMANS; KETOPROFEN;

EID: 80052350783     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. HAROUTIUNIAN S, DRENNAN DA, LIPMAN AG. Topical NSAID therapy for musculoskeletal pain. Pain Med 2010; 11: 535-549.
2. ALTMAN R, BARKIN RL. Topical therapy for osteoarthritis: clinical and pharmacologic perspectives. Postgrad Med 2009; 121: 139-147.
3. ZHANG W, DOHERTY M, LEEB BF, ALEKSEEVA L, ARDEN NK, BULSMA JW, DINÇER F, DZIEDZIC K, HÄUSELMANN HJ, HERRERO-BEAUMONT G, KAKLAMANIS P, LOHMANDER S, MAHEU E, MARTÍN-MOLA E, PAVELKA K, PUNZI L, REITER S, SAUTNER J, SMOLEN J, VERBRUGGEN G, ZIMMERMANN-GÓRSKA I. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 377-388.
4. ZHANG W, MOSKOWITZ RW, NUKI G, ABRAMSON S, ALTMAN RD, ARDEN N, BIERMA-ZEINSTRA S, BRANDT KD, CROFT P, DOHERTY M, DOUGADOS M, HOCHBERG M, HUNTER DJ, KWOH K, LOHMANDER LS, TUGWELL P. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007; 15: 981-1000.
5. MASSEY T, DERRY S, MOORE RA, MCQUAY HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev 2010; 6: CD007402.
6. SARZI-PUTTINI P, ATZENI F, LANATA L, BAGNASCO M, COLOMBO M, FISCHER F, D'IMPORZANO M. Pain and ketoprofen: what is its role in clinical practice? Reumatismo 2010; 62: 172-188.
7. VEYS EM. 20 years' experience with ketoprofen. Scand J Rheumatol Suppl 1991; 90 (Suppl.): 1-44.
8. KANTOR TG. Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy 1986; 6: 93-103.
9. BALLERINI R, CASINI A, CHINOL M, MANNUCCI C, GIACCAI L, SALVI M. Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels. Int J Clin Pharmacol Res 1986; 6: 69-72.
10. FLOUVAT B, ROUX A, DELHOTAL-LANDES B. Pharmacokinetics of ketoprofen in man after repeated percutaneous administration. Arzneimittelforschung 1989; 39: 812-815.
11. PARIER J. Pilot study on the anti-inflammatory activity of ketoprofen after topical administration of a gel to 20 patients who were undergoing arthroscopy of the knee. FG 14. Company Report, 1994.
12. MARTY JP. Ketoprofen in vitro percutaneous absorption through human skin from 4 gel formulations. BC/FE-G/069/2002. Company Report, 2002.
13. PIPPI F. In vitro evaluation on human skin of the diffusion of ketoprofen from topical products (Fasturn gel, Ketoprofen 2-5% UV gel spray). RF022MN02.doc. Company Report, 2002.
14. CARABAZA A, CABRÉ F, ROTLLAN E, GÓMEZ M, GUTIÉRREZ M, GARCÍA ML, MAULEÓN D. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal anti-inflammatory drugs. J Clin Pharmacol 1996; 36: 505-512.
15. JULOU L, GUYONNET JC, DUCROT R, FOURNEL J, PASQUET J. Ketoprofen (19.583 R.R) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties-outline of toxicological and pharmacokinetic data. Scand J Rheumatol Suppl 1976; (Suppl): 33-44.
16. MIGNE J, VEDRINE Y, BOURAT G, FOURNEL J, HEUSSE D. Action of ketoprofen on hepatic lysosome in the rat. Rheumatol Rehabil 1976; (Suppl): 15-19.
17. PREZIOSI P. Effects of Fastum Gel (ketoprofen) on prostaglandin concentrations in synovial fluid and the platelet output of thromboxane B2. Company Report, data on file.
18. CANDELA V. Single-blind study on the therapeutic effects of Fastum Gel in the traumatic lesions due to sporting practices. Company Report, 1985.
19. ODAGLIA G. Sports Minor Traumatology: Results of a double blind controlled clinical study, ketoprofen (Fastum Gel 2.5%) versus placebo. Company Report, 1987.
20. DREISER RL. Clinical trial - Fastum Gel. FG-6. Company Report, 1988.
21. JULIEN D. Analysis of data from Clinical Trial FG8, comparing Fastum Gel from Laboratories A. Menarini S.a.S. with an excipient, in the treatment of tendonitis. Company Report, 1988.
22. AUGY S. Randomised, double-blind trial with parallel groups to evaluate the efficacy and tolerability of Fastum Gel by comparison with placebo in the treatment of acute low back pain of disc origin. FG-11. Company Report, 1992.
23. DREISER RL. Comparative trial of 2.5% ketoprofen gel (Fastum Gel) versus placebo in the treatment of osteoarthritis of the knee. FG-12. Company Report, 1994.
24. GUILLAUME M. Study of efficacy and tolerability of ketum gel versus placebo in the treatment of osteoarthritis of the knee. FG-10. Company Report, 1989.
25. MATUCCI-CERINIC M, CASINI A. Ketoprofen vs etofenamate in a controlled double-blind study: evidence of topical effectiveness in soft tissue rheumatic pain. Int J Clin Pharmacol Res 1988; 8: 157-160.
26. ROZEMBERG P. A phase IV, randomised, double-blind, double-dummy, two parallel group study: Ketum 2.5% gel versus oral diclofenac 50 mg in symptomatic hand osteoarthritis. MeFR/05/Ket-Rhu/001. Company Report, 2009.
27. BECHELLI P. Topical treatment of traumatic sport lesions with 2-(-benzoylphenyl)propionic acid in the treatment of traumatic sports injuries. Company Report, 1980.
28. CANUTI M. Fastum Gel in physical therapy: iontophoresis and ultrasonic. Translation of article in: G It Ric Clin Terap 1981; II: 81.
29. NAZZARO D. Experiences in the treatment of minor traumatology with ultrasound and Ketoprofen. Clinica Europea 1983; XXII (3) [no pages number given].
30. BOCCA C. Our experiences of sonophoresis with ketoprofen in the pharmaceutical form of a gel. Company Report, 1985.
31. DANILE V. Iontophoresis application of 2-(3-benzoyl-phenyl)-propionic acid in patients suffering from osphyalgia. Company Report, 1984.
32. SPAGGIARI G. Clinical experimentation on the topical use of 2-(3-benzoyl-phenyl)-propionic acid in post traumatic, inflammatory and degenerative conditions. Company Report, 1985.
33. CASINI A. Study to evaluate the clinical activity and tolerance of ketoprofen topically administered in minor sports traumatology. Publication is authorized: Riv It Ortop Traumatol 1986; XXVI (2) [no pages numbers given].
34. MOORE RA, TRAMER MR, CARROLL D, WIFFEN PJ, MCQUAY HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. Br Med J 1998; 316: 333-338.
35. MASON L, MOORE RA, EDWARDS JE, DERRY S, MCQUAY HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004; 5: 10.
36. JORDAN KM, ARDEN NK, DOHERTY M, BANNWARTH B, BIJLSMA JW, DIEPPE P, GUNTHER K, HAUSELMANN H, HERRERO-BEAUMONT G, KAKLAMANIS P, LOHMANDER S, LEEB B, LEQUESNE M, MAZIERES B, MARTIN-MOLA E, PAVELKA K, PENDLETON A, PUNZI L, SERNI U, SWOBODA B, VERBRUGGEN G, ZIMMERMAN-GORSKA I, DOUGADOS M; STANDING COMMITTEE FOR INTERNATIONAL CLINICAL STUDIES INCLUDING THERAPEUTIC TRIALS ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-1155.
37. CONAGHAN PG, DICKSON J, GRANT RL; GUIDELINE DEVELOPMENT GROUP. Care and management of osteoarthritis in adults: summary of NICE guidance. Br Med J 2008; 336: 502-503.
38. AVOUAC B, TEULE M. Ketoprofen: the European experience. J Clin Pharmacol 1988; 28(12 Suppl.): S2-S7.
39. HINDSEN M, ISAKSSON M, PERSSON L, ZIMERSSON E, BRUZE M. Photoallergic contact dermatitis from ketoprofen induced by drug-contaminated personal objects. J Am Acad Dermatol 2004; 50: 215-219.
40. MATTHIEU L, MEULEMAN L, VAN HECKE E, BLONDEEL A, DEZFOULIAN B, CONSTANDT L, GOOSSENS A. Contact and photocontact allergy to ketoprofen. The Belgian experience. Contact Dermatitis 2004; 50: 238-241.
41. BLACKHALL K. Finding studies for inclusion in systematic reviews of interventions for injury prevention the importance of grey and unpublished literature. Inj Prev 2007; 13: 359.